ArticleAnnals of vascular surgery2025
Significant Radiation Reduction Using Cloud-Based AI Imaging in Manually Matched Cohort of Complex Aneurysm Repair.
Article in Annals of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCloud-based, surgical augmented intelligence (Cydar Medical, Cambridge, United Kingdom) can be used for surgical planning and intraoperative imaging guidance during complex endovascular aortic procedures. We aim to evaluate radiation exposure, operative safety metrics, and postoperative renal outcomes following implementation of Cydar imaging guidance using a manually matched cohort of aortic procedures.
methodsWe retrospectively reviewed our prospectively maintained database of endovascular aortic cases. Patients repaired using Cydar imaging were matched to patients who underwent a similar procedure without using Cydar. Matching was performed manually on a 1:1 basis using anatomy, device configuration, number of branches/fenestrations, and adjunctive procedures including in-situ laser fenestration. Radiation, contrast use, and other operative metrics were compared. Preoperative and postoperative maximum creatinine was compared to assess for acute kidney injury (AKI) based on risk, injury, failure, loss of kidney function, and end-stage kidney disease (RIFLE) criteria.
resultsHundred patients from 2012 to 2023 were identified: 50 cases (38 fenestrated endovascular aortic repairs, 2 thoracic endovascular aortic repairs, 3 octopus-type thoracoabdominal aortic aneurysm repair, 7 endovascular aneurysm repairs) where Cydar imaging was used, with suitable matches to 50 non-Cydar cases. Baseline characteristics including body mass index did not differ significantly between the 2 groups (27.8 ± 5.6 vs. 26.7 ± 6.1; P = 0.31). Radiation dose was significantly lower in the Cydar group (2529 ± 2256 vs. 3676 ± 2976 mGy; P < 0.03), despite there being no difference in fluoroscopy time (51 ± 29.4 vs. 58 ± 37.2 min; P = 0.37). Contrast volume (94 ± 37.4 vs. 93 ± 43.9 mL; P = 0.73), estimated blood loss (169 ± 223 vs. 193 ± 222 mL; P = 0.97), and procedure time (154 ± 78 vs. 165 ± 89.1 min) did not differ significantly. Additionally, Cydar versus non-Cydar patients did not show a significant difference between precreatinine and postcreatinine changes (0.13 ± 0.08 vs. 0.05 ± 0.07; P = 0.34). Only one patient in the non-Cydar group met RIFLE criteria for AKI postoperatively.
conclusionThe use of cloud-based augmented intelligence imaging was associated with a significant reduction in radiation dose in a cohort of matched aortic procedures but did not appear to affect other parameters or renal function. Even with advanced imaging, surgeons should remain conscientious about radiation safety and administration of nephrotoxic contrast agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.